| Members |
targetComponentId |
| Graphosid spider |
Order Araneae (organism) |
| Gray elder pollen |
Grey alder pollen |
| fett |
Automotive grease (substance) |
| stortålambå |
Flap (substance) |
| Great vessel repair with unlisted major procedure |
Repair of great vessels |
| grön färg |
Green color (qualifier value) |
| Greenfieldfilter |
Vena cava filter |
| malning, aktivitet |
Abrasion - action |
| griseofulvin av mikrostorlek, 125 mg/5 ml, suspension |
Product containing precisely griseofulvin 25 milligram/1 milliliter conventional release oral suspension (clinical drug) |
| Griseofulvin, microsize 125mg/mL suspension |
Product containing precisely griseofulvin 25 milligram/1 milliliter conventional release oral suspension (clinical drug) |
| ljumsklambå |
Flap (substance) |
| Gross stress reaction |
Acute stress disorder |
| Guaiac test |
Chemical test for occult blood |
| guajfenesin 50 mg +oxtrifyllin 100 mg, elixir |
Product containing only guaifenesin and theophylline in oral dose form (medicinal product form) |
| guajfenesin 100 mg + teofyllinnatriumglycinat 300 mg, elixir |
Product containing only guaifenesin and theophylline in oral dose form (medicinal product form) |
| guajfenesin 100 mg/5 ml, sirap |
Product containing precisely guaifenesin 20 milligram/1 milliliter conventional release oral solution (clinical drug) |
| guajfenesin 1 200 mg + dextrometorfan 60 mg, depåtablett |
Dextromethorphan hydrobromide 60 mg and guaifenesin 1.2 g prolonged-release oral tablet |
| guajfenesin 1 200 mg + pseudoefedrin 120 mg, depåtablett |
Product containing precisely guaifenesin 1.2 gram and pseudoephedrine hydrochloride 120 milligram/1 each prolonged-release oral tablet (clinical drug) |
| guajfenesin 1 200 mg, tablett med modifierad frisättning |
Product containing only guaifenesin in oral dose form (medicinal product form) |
| guajfenesin 1 200 mg med modifierad frisättning + dextrometorfan 60 mg, tablett |
Dextromethorphan hydrobromide 60 mg and guaifenesin 1.2 g prolonged-release oral tablet |
| guajfenesin 1 200 mg med modifierad frisättning + pseudoefedrin 120 mg, tablett |
Product containing precisely guaifenesin 1.2 gram and pseudoephedrine hydrochloride 120 milligram/1 each prolonged-release oral tablet (clinical drug) |
| guajfenesin 1 200 mg, depåtablett |
Product containing only guaifenesin in oral dose form (medicinal product form) |
| guajfenesin 300 mg, kapsel med modifierad frisättning |
Product containing only guaifenesin in oral dose form (medicinal product form) |
| guajfenesin 300 mg, depåkapsel |
Product containing only guaifenesin in oral dose form (medicinal product form) |
| guajfenesin 50 mg/ml |
Product containing only guaifenesin (medicinal product) |
| guajfenesin 600 mg + dextrometorfan 30 mg, depåtablett |
Product containing precisely dextromethorphan hydrobromide 30 milligram and guaifenesin 600 milligram/1 each prolonged-release oral tablet (clinical drug) |
| guajfenesin 600 mg + pseudoefedrin 60 mg, depåtablett |
Product containing precisely guaifenesin 600 milligram and pseudoephedrine hydrochloride 60 milligram/1 each prolonged-release oral tablet (clinical drug) |
| guajfenesin 600 mg, kapsel med modifierad frisättning |
Product containing only guaifenesin in oral dose form (medicinal product form) |
| guajfenesin 600 mg med modifierad frisättning + dextrometorfan 30 mg, tablett |
Product containing precisely dextromethorphan hydrobromide 30 milligram and guaifenesin 600 milligram/1 each prolonged-release oral tablet (clinical drug) |
| guajfenesin 600 mg med modifierad frisättning + pseudoefedrin 60 mg, tablett |
Product containing precisely guaifenesin 600 milligram and pseudoephedrine hydrochloride 60 milligram/1 each prolonged-release oral tablet (clinical drug) |
| guajfenesin 600 mg, depåkapsel |
Product containing only guaifenesin in oral dose form (medicinal product form) |
| guanetidinmonosulfat 0,25 %, ögondroppar |
Product containing precisely guanethidine 2.5 milligram/1 milliliter conventional release eye solution (clinical drug) |
| guanetidinmonosulfat 0,5 %, ögondroppar |
Guanethidine 5 mg/mL eye solution |
| guanetidinmonosulfat 1 %, ögondroppar |
Product containing precisely guanethidine 10 milligram/1 milliliter conventional release eye solution (clinical drug) |
| guanetidinmonosulfat 2 %, ögondroppar |
Product containing precisely guanethidine 20 milligram/1 milliliter conventional release eye solution (clinical drug) |
| guanetidinmonosulfat 3 %, ögondroppar |
Product containing precisely guanethidine 30 milligram/1 milliliter conventional release eye solution (clinical drug) |
| guanetidinmonosulfat 0,25 % + adrenalin 0,05 %, ögondroppar |
Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution |
| guanetidinmonosulfat 0,5 % + adrenalin 0,1 %, ögondroppar |
Adrenaline (as adrenaline acid tartrate) 1 mg/mL and guanethidine 5 mg/mL eye solution |
| guanetidinmonosulfat 1 % + adrenalin 0,5 %, ögondroppar |
Adrenaline (as adrenaline acid tartrate) 5 mg/mL and guanethidine 10 mg/mL eye solution |
| Guanfacine hydrochloride 1.0mg tablet |
Guanfacine (as guanfacine hydrochloride) 1 mg oral tablet |
| guanfacinhydrokorid 1 mg, depåtablett |
Product containing precisely guanfacine (as guanfacine hydrochloride) 1 milligram/1 each prolonged-release oral tablet (clinical drug) |
| guanfacinhydrokorid 2 mg, depåtablett |
Product containing precisely guanfacine (as guanfacine hydrochloride) 2 milligram/1 each prolonged-release oral tablet (clinical drug) |
| guanfacinhydrokorid 3 mg, depåtablett |
Product containing precisely guanfacine (as guanfacine hydrochloride) 3 milligram/1 each prolonged-release oral tablet (clinical drug) |
| guanfacinhydrokorid 4 mg, depåtablett |
Guanfacine (as guanfacine hydrochloride) 4 mg prolonged-release oral tablet |
| Guide wire placement via previous catheter |
Insertion - action (qualifier value) |
| Gummata of yaws |
Nodular late yaws |
| Gummatous frambeside |
Nodular late yaws |
| krut |
Gunpowder (substance) |
| Gunstock deformity |
Acquired cubitus varus |
| Güntherfilter för temporärt bruk |
Temporary vena cava filter |
| Gynecological laparoscopy NEC |
Laparoscopy of female pelvis |
| H/O: anaesthetic allergy |
Allergy to drug |
| H/O: analgesic allergy |
Allergy to drug |
| H/O: cat allergy |
Allergy to Felis catus protein (finding) |
| H/O: cat allergy |
Allergy to Felis catus protein (finding) |
| H/O: drug dependency |
History of substance dependency (situation) |
| HPV - Human papillomavirus test declined |
Screening for Human papillomavirus declined (situation) |
| HPV - Human papillomavirus test declined |
Screening for Human papillomavirus declined (situation) |
| HTLV 2 nucleic acid detection |
HTLV 2 nucleic acid assay |
| HTLV 2 nucleic acid detection |
HTLV 2 nucleic acid assay |
| HTLV 2 nucleic acid detection |
HTLV 2 nucleic acid assay |
| HTLV-BLV virus |
Genus Deltaretrovirus (organism) |
| HTLV-III/LAV infection |
Human immunodeficiency virus infection |
| Habitual aborter |
Recurrent miscarriage |
| Had short umbilical cord |
History of short umbilical cord (situation) |
| hade kort navelsträng |
History of short umbilical cord (situation) |
| kolja, livsmedel |
Haddock (substance) |
| Haematuria NOS |
Blood in urine |
| Haemobartonella canis |
Mycoplasma haemocanis (organism) |
| Haemobartonella felis |
Mycoplasma haemofelis (organism) |
| Haemobartonella muris |
Mycoplasma haemomuris (organism) |
| Haemobartonella species |
Genus Mycoplasma |
| Haemobartonellosis |
Mycoplasmal anemia (disorder) |
| Haemoglobin very high |
Hemoglobin above reference range |
| Haemoglobin very low |
Hemoglobin below reference range (finding) |
| Haemophilus actinomycetemcomitans |
Aggregatibacter actinomycetemcomitans |
| Haemophilus agni |
Histophilus somni (organism) |
| Haemophilus aphrophilus |
Aggregatibacter aphrophilus |
| Haemophilus canis |
Haemophilus haemoglobinophilus |
| vaccination mot Haemophilus influenzae |
Administration of vaccine product containing only Haemophilus influenzae type b antigen (procedure) |
| Haemophilus pleuropneumoniae |
Actinobacillus pleuropneumoniae |
| Haemophilus segnis |
Aggregatibacter segnis |
| Haemophilus somnus |
Histophilus somni (organism) |
| Haemorrhagic fever with renal syndrome |
Hemorrhagic fever with renal syndrome (disorder) |
| Hairworms |
Phylum Nematomorpha (organism) |
| infantil pseudokolera |
Acute diarrhea (disorder) |
| Half base syndrome |
Cranial nerve disorder |
| hallucinogen, icke läkemedel |
Hallucinogenic agent (substance) |
| hallucinogenberoende med nuvarande användning |
Hallucinogen dependence |
| haloperidol 100 mg, injektionsvätska, lösning, ampull |
Haloperidol only product in parenteral dose form |
| Haloperidol 100mg/mL injection |
Haloperidol only product in parenteral dose form |
| haloperidol 5 mg, injektionsvätska, lösning, ampull |
Haloperidol only product in parenteral dose form |
| Haloperidol 5mg/mL injection |
Haloperidol only product in parenteral dose form |
| haloperidoldekanoat 50 mg/ml, injektionsvätska, lösning, ampull |
Haloperidol only product in parenteral dose form |
| Haloperidol decanoate 50mg/mL solution |
Haloperidol only product in parenteral dose form |
| handlambå |
Flap (substance) |
| ospecificerad handlambå, icke kärlsäkrad |
Random pattern flap |
| hjälpmedel för person med funktionsnedsättning |
Provision of aid for disability (procedure) |
| barn med funktionsnedsättning |
Child of subject has disability (situation) |
| Hanen-program för tidigt språk |
Hanen program of language development |
| Hansenula anomala |
Wickerhamomyces anomalus (organism) |
FHIR